Global Anti-allergic Therapeutics Market is expected to reach $43.58 Bn. by 2029 from $28.04 Bn. in 2022, at a CAGR of 6.5% during forecast period.Global Anti-allergic Therapeutics Market Overview:
Allergies are the immune system’s hypersensitivity reactions to chemicals that penetrate or come into contact with the human body. Treatment for allergies varies depending on the seriousness of the disease and the type of allergies the individual has.To know about the Research Methodology :- Request Free Sample Report
Global Anti-allergic Therapeutics Market Dynamics:
Increasing prevalence of allergic diseases is expected to drive the global market growth. The rising prevalence of different forms of allergies, increasing investments from the key manufacturers for the production of novel allergic therapies, and the rising awareness of self-medication are all driving the market forward. Increased patient population with different types of allergies, changing lifestyles, unhealthy eating habits, growing demand for advanced allergy treatment therapy, increased research and development activities, and government initiatives are some of the factors driving the global anti-allergic Therapeutics market forward. Over the last decade, there have been a rise in over-the-counter (OTC) medications as a result of self-medication. These OTC medications are less expensive and more available to a larger number of patients, resulting in increased drug procurement. More than half of the population in North America had positive responses to one or more allergens. In the United States, allergic rhinitis affects between 10% and 30% of all adults and up to 40% of infants. The American College of Allergy, Asthma & Immunology states that allergies are the sixth leading cause of chronic disease in the United States. In April 2020 Menlo Therapeutics Inc. reported promising results from two ongoing Phase-III clinical trials assessing the safety and efficacy of oral serlopitant for the treatment of Pruritus, a form of skin allergy. However, restraining factors such as high costs of immunotherapy for allergy treatment, stringent drug regulatory approval and immunotherapy side effects impose challenges on the market growth. The report has profiled twenty key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for future hot spot in APAC region.Segment Analysis:
The Global Anti-allergic Therapeutics Market is segmented on the basis of Allergy Type, Therapy and Dosage Form. Based on Allergy Type, the Rhinitis allergy segment dominated the global market. The segment is projected to grow by a CAGR of 5.5% during the forecast period. Allergic rhinitis is caused due to inhaling tiny allergen spores. Dust mites, pollen, and spores, as well as animal skin, urine, and saliva, are the most common airborne allergens that cause rhinitis. An increase in government-funded healthcare services to raise awareness about allergic diseases and the rising incidence of allergic rhinitis propel the segment growth. The European Academy of Allergy and Clinical Immunology (EAACI) states that Rhinitis affected about 400 million people worldwide in 2017. Based on Therapy, the anti-allergy drugs segment dominated the global market in 2022 and is expected to continue its dominance during the forecast period. The segment experiences lucrative growth due to the ease with which oral dosage forms can be self-administered, as well as their compactness and ease of manufacture. Antihistamines and corticosteroids such as prednisolone, which can be injected or taken orally, have aided in the steady growth of the anti-allergy therapeutics market.Global Anti-allergic Therapeutics Market Regional Insights:
North America accounted for dominant market share in 2022 and is expected to continue the dominance throughout forecast period. North America is expected to lead the global market at a CAGR of XX% during the forecast period. Factors encouraging the market growth in the region include the high prevalence of respiratory allergic disorders, increasing awareness of allergy diagnostics, and the adoption of in vitro blood tests. Europe holds the second largest market share owing to its established pharmaceutical industry and growing demand for therapeutics. Asthma is the leading cause of large allergic patient pool in North America. It accounted for 3.8 million asthma patients in 2022. The market is expected to develop significantly in the future due to the high death rates associated with asthma and increased investment in asthma in this region. APAC is expected to witness lucrative growth during forecast period. During the forecast period, Asia Pacific is expected to grow at the fastest pace. This is due to the growth of adequate healthcare facilities, the prevalence of food allergies among the younger population, and the entry of key players into the healthcare sector with adequate allergy treatment investments. The report also helps in understanding Global Anti-allergic Therapeutics Market dynamics, structure by analyzing the market segments and project the Global Anti-allergic Therapeutics Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Anti-allergic Therapeutics Market make the report investor’s guide.Key Developments:
Johnson & Johnson's investigational antihistamine lens received positive Phase 3 findings in March 2019. ITULAZAX, Alk-Abello A/latest S's tree SLIT-tablet, was released in Germany in September 2019. Northern Europe has a high prevalence of tree pollen allergies, making Germany a key market for the medication.Global Anti-allergic Therapeutics Market Scope: Inquire before buying
Anti-allergic Therapeutics Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 28.04 Bn. Forecast Period 2022 to 2029 CAGR: 6.5% Market Size in 2029: US $ 43.58 Bn. Segments Covered: by Allergy Type Eye Allergy Rhinitis Asthma Skin Allergy Food Allergies Other Allergies by Therapy Anti-Allergy Drugs Antihistamines Corticosteroids Decongestants Other Drugs Immunotherapy Sub-cutaneous Immunotherapy (SCIT) Sub-Lingual Immunotherapy (SLIT) by Dosage Form Oral Inhalers Intranasal Global Anti-allergic Therapeutics Market, By Region:
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest) South America (Brazil, Argetina and Rest of South America)Global Anti-allergic Therapeutics Market, Key Players
1. Allergy Therapeutics 2. Allergan, Plc. 3. Genentech, Inc. 4. Collegium Pharmaceutical, Inc. 5. McNeil Consumer Healthcare 6. Strides Arcolab 7. Allergopharma GmbH & Co. KG. 8. GlaxoSmithKline 9. ALK-Abelló A/S 10. Sallergenes Greer 11. Sanofi SA 12. Johnson & Johnson 13. Merck Co. In 14. F. Hoffmann-La Roche AG 15. Novartis AG 16. Cipla Inc 17. Aurobindo Pharma 18. Zydus Cadila 19. Lupin 20. Mylan N.V Frequently Asked Questions: 1. Which region has the largest share in Global Anti-allergic Therapeutics Market? Ans: Asia Pacific region held the highest share in 2022. 2. What is the growth rate of Global Anti-allergic Therapeutics Market? Ans: The Global Anti-allergic Therapeutics Market is growing at a CAGR of 6.5 % during forecasting period 2023-2029. 3. What is scope of the Global Anti-allergic Therapeutics Market report? Ans: Global Anti-allergic Therapeutics Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. What was the Global Anti-allergic Therapeutics Market size in 2022? Ans: The Global Anti-allergic Therapeutics market was valued at US$ 28.04 Bn. In 2022. 5. What is the study period of this Market? Ans: The Global Anti-allergic Therapeutics Market is studied from 2022 to 2029.
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Anti-allergic Therapeutics Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2022 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Anti-allergic Therapeutics Market 3.4. Geographical Snapshot of the Anti-allergic Therapeutics Market, By Manufacturer share 4. Global Anti-allergic Therapeutics Market Overview, 2022-2029 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Anti-allergic Therapeutics Market 5. Supply Side and Demand Side Indicators 6. Global Anti-allergic Therapeutics Market Analysis and Forecast, 2022-2029 6.1. Global Anti-allergic Therapeutics Market Size & Y-o-Y Growth Analysis. 7. Global Anti-allergic Therapeutics Market Analysis and Forecasts, 2022-2029 7.1. Market Size (Value) Estimates & Forecast By Allergy Type, 2022-2029 7.1.1. Eye Allergy 7.1.2. Rhinitis 7.1.3. Asthma 7.1.4. Skin Allergy 7.1.5. Food Allergies 7.1.6. Other Allergies 7.2. Market Size (Value) Estimates & Forecast By Therapy, 2022-2029 7.2.1. Anti-Allergy Drugs 7.2.1.1. Antihistamines 7.2.1.2. Corticosteroids 7.2.1.3. Decongestants 7.2.1.4. Other Drugs 7.2.2. Immunotherapy 7.2.2.1. Sub-cutaneous Immunotherapy (SCIT) 7.2.2.2. Sub-Lingual Immunotherapy (SLIT) 7.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 7.3.1. Oral 7.3.2. Inhalers 7.3.3. Intranasal 8. Global Anti-allergic Therapeutics Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2022-2029 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Anti-allergic Therapeutics Market Analysis and Forecasts, 2022-2029 9.1. Market Size (Value) Estimates & Forecast By Allergy Type, 2022-2029 9.1.1. Eye Allergy 9.1.2. Rhinitis 9.1.3. Asthma 9.1.4. Skin Allergy 9.1.5. Food Allergies 9.1.6. Other Allergies 9.2. Market Size (Value) Estimates & Forecast By Therapy, 2022-2029 9.2.1. Anti-Allergy Drugs 9.2.1.1. Antihistamines 9.2.1.2. Corticosteroids 9.2.1.3. Decongestants 9.2.1.4. Other Drugs 9.2.2. Immunotherapy 9.2.2.1. Sub-cutaneous Immunotherapy (SCIT) 9.2.2.2. Sub-Lingual Immunotherapy (SLIT) 9.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 9.3.1. Oral 9.3.2. Inhalers 9.3.3. Intranasal 10. North America Anti-allergic Therapeutics Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Anti-allergic Therapeutics Market Analysis and Forecasts, 2022-2029 11.1. Market Size (Value) Estimates & Forecast By Allergy Type, 2022-2029 11.2. Market Size (Value) Estimates & Forecast By Therapy, 2022-2029 11.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 12. Canada Anti-allergic Therapeutics Market Analysis and Forecasts, 2022-2029 12.1. Market Size (Value) Estimates & Forecast By Allergy Type, 2022-2029 12.2. Market Size (Value) Estimates & Forecast By Therapy, 2022-2029 12.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 13. Mexico Anti-allergic Therapeutics Market Analysis and Forecasts, 2022-2029 13.1. Market Size (Value) Estimates & Forecast By Allergy Type, 2022-2029 13.2. Market Size (Value) Estimates & Forecast By Therapy, 2022-2029 13.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 14. Europe Anti-allergic Therapeutics Market Analysis and Forecasts, 2022-2029 14.1. Market Size (Value) Estimates & Forecast By Allergy Type, 2022-2029 14.2. Market Size (Value) Estimates & Forecast By Therapy, 2022-2029 14.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 15. Europe Anti-allergic Therapeutics Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Anti-allergic Therapeutics Market Analysis and Forecasts, 2022-2029 16.1. Market Size (Value) Estimates & Forecast By Allergy Type, 2022-2029 16.2. Market Size (Value) Estimates & Forecast By Therapy, 2022-2029 16.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 17. France Anti-allergic Therapeutics Market Analysis and Forecasts, 2022-2029 17.1. Market Size (Value) Estimates & Forecast By Allergy Type, 2022-2029 17.2. Market Size (Value) Estimates & Forecast By Therapy, 2022-2029 17.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 18. Germany Anti-allergic Therapeutics Market Analysis and Forecasts, 2022-2029 18.1. Market Size (Value) Estimates & Forecast By Allergy Type, 2022-2029 18.2. Market Size (Value) Estimates & Forecast By Therapy, 2022-2029 18.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 19. Italy Anti-allergic Therapeutics Market Analysis and Forecasts, 2022-2029 19.1. Market Size (Value) Estimates & Forecast By Allergy Type, 2022-2029 19.2. Market Size (Value) Estimates & Forecast By Therapy, 2022-2029 19.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 20. Spain Anti-allergic Therapeutics Market Analysis and Forecasts, 2022-2029 20.1. Market Size (Value) Estimates & Forecast By Allergy Type, 2022-2029 20.2. Market Size (Value) Estimates & Forecast By Therapy, 2022-2029 20.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 21. Sweden Anti-allergic Therapeutics Market Analysis and Forecasts, 2022-2029 21.1. Market Size (Value) Estimates & Forecast By Allergy Type, 2022-2029 21.2. Market Size (Value) Estimates & Forecast By Therapy, 2022-2029 21.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 22. CIS Countries Anti-allergic Therapeutics Market Analysis and Forecasts, 2022-2029 22.1. Market Size (Value) Estimates & Forecast By Allergy Type, 2022-2029 22.2. Market Size (Value) Estimates & Forecast By Therapy, 2022-2029 22.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 23. Rest of Europe Anti-allergic Therapeutics Market Analysis and Forecasts, 2022-2029 23.1. Market Size (Value) Estimates & Forecast By Allergy Type, 2022-2029 23.2. Market Size (Value) Estimates & Forecast By Therapy, 2022-2029 23.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 24. Asia Pacific Anti-allergic Therapeutics Market Analysis and Forecasts, 2022-2029 24.1. Market Size (Value) Estimates & Forecast By Allergy Type, 2022-2029 24.2. Market Size (Value) Estimates & Forecast By Therapy, 2022-2029 24.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 25. Asia Pacific Anti-allergic Therapeutics Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Anti-allergic Therapeutics Market Analysis and Forecasts, 2022-2029 26.1. Market Size (Value) Estimates & Forecast By Allergy Type, 2022-2029 26.2. Market Size (Value) Estimates & Forecast By Therapy, 2022-2029 26.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 27. India Anti-allergic Therapeutics Market Analysis and Forecasts, 2022-2029 27.1. Market Size (Value) Estimates & Forecast By Allergy Type, 2022-2029 27.2. Market Size (Value) Estimates & Forecast By Therapy, 2022-2029 27.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 28. Japan Anti-allergic Therapeutics Market Analysis and Forecasts, 2022-2029 28.1. Market Size (Value) Estimates & Forecast By Allergy Type, 2022-2029 28.2. Market Size (Value) Estimates & Forecast By Therapy, 2022-2029 28.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 29. South Korea Anti-allergic Therapeutics Market Analysis and Forecasts, 2022-2029 29.1. Market Size (Value) Estimates & Forecast By Allergy Type, 2022-2029 29.2. Market Size (Value) Estimates & Forecast By Therapy, 2022-2029 29.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 30. Australia Anti-allergic Therapeutics Market Analysis and Forecasts, 2022-2029 30.1. Market Size (Value) Estimates & Forecast By Allergy Type, 2022-2029 30.2. Market Size (Value) Estimates & Forecast By Therapy, 2022-2029 30.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 31. ASEAN Anti-allergic Therapeutics Market Analysis and Forecasts, 2022-2029 31.1. Market Size (Value) Estimates & Forecast By Allergy Type, 2022-2029 31.2. Market Size (Value) Estimates & Forecast By Therapy, 2022-2029 31.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 32. Rest of Asia Pacific Anti-allergic Therapeutics Market Analysis and Forecasts, 2022-2029 32.1. Market Size (Value) Estimates & Forecast By Allergy Type, 2022-2029 32.2. Market Size (Value) Estimates & Forecast By Therapy, 2022-2029 32.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 33. Middle East Africa Anti-allergic Therapeutics Market Analysis and Forecasts, 2022-2029 33.1. Market Size (Value) Estimates & Forecast By Allergy Type, 2022-2029 33.2. Market Size (Value) Estimates & Forecast By Therapy, 2022-2029 33.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 34. Middle East Africa Anti-allergic Therapeutics Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Anti-allergic Therapeutics Market Analysis and Forecasts, 2022-2029 35.1. Market Size (Value) Estimates & Forecast By Allergy Type, 2022-2029 35.2. Market Size (Value) Estimates & Forecast By Therapy, 2022-2029 35.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 36. GCC Countries Anti-allergic Therapeutics Market Analysis and Forecasts, 2022-2029 36.1. Market Size (Value) Estimates & Forecast By Allergy Type, 2022-2029 36.2. Market Size (Value) Estimates & Forecast By Therapy, 2022-2029 36.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 37. Egypt Anti-allergic Therapeutics Market Analysis and Forecasts, 2022-2029 37.1. Market Size (Value) Estimates & Forecast By Allergy Type, 2022-2029 37.2. Market Size (Value) Estimates & Forecast By Therapy, 2022-2029 37.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 38. Nigeria Anti-allergic Therapeutics Market Analysis and Forecasts, 2022-2029 38.1. Market Size (Value) Estimates & Forecast By Allergy Type, 2022-2029 38.2. Market Size (Value) Estimates & Forecast By Therapy, 2022-2029 38.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 39. Rest of ME&A Anti-allergic Therapeutics Market Analysis and Forecasts, 2022-2029 39.1. Market Size (Value) Estimates & Forecast By Allergy Type, 2022-2029 39.2. Market Size (Value) Estimates & Forecast By Therapy, 2022-2029 39.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 40. South America Anti-allergic Therapeutics Market Analysis and Forecasts, 2022-2029 40.1. Market Size (Value) Estimates & Forecast By Allergy Type, 2022-2029 40.2. Market Size (Value) Estimates & Forecast By Therapy, 2022-2029 40.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 41. South America Anti-allergic Therapeutics Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Anti-allergic Therapeutics Market Analysis and Forecasts, 2022-2029 42.1. Market Size (Value) Estimates & Forecast By Allergy Type, 2022-2029 42.2. Market Size (Value) Estimates & Forecast By Therapy, 2022-2029 42.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 43. Argentina Anti-allergic Therapeutics Market Analysis and Forecasts, 2022-2029 43.1. Market Size (Value) Estimates & Forecast By Allergy Type, 2022-2029 43.2. Market Size (Value) Estimates & Forecast By Therapy, 2022-2029 43.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 44. Rest of South America Anti-allergic Therapeutics Market Analysis and Forecasts, 2022-2029 44.1. Market Size (Value) Estimates & Forecast By Allergy Type, 2022-2029 44.2. Market Size (Value) Estimates & Forecast By Therapy, 2022-2029 44.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Anti-allergic Therapeutics Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. Allergy Therapeutics 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Allergan, Plc. 45.3.3. Genentech, Inc. 45.3.4. Collegium Pharmaceutical, Inc. 45.3.5. McNeil Consumer Healthcare 45.3.6. Strides Arcolab 45.3.7. Allergopharma GmbH & Co. KG. 45.3.8. GlaxoSmithKline 45.3.9. ALK-Abelló A/S 45.3.10. Sallergenes Greer 45.3.11. Sanofi SA 45.3.12. Johnson & Johnson 45.3.13. Merck Co. In 45.3.14. F. Hoffmann-La Roche AG 45.3.15. Novartis AG 45.3.16. Cipla Inc 45.3.17. Aurobindo Pharma 45.3.18. Zydus Cadila 45.3.19. Lupin 45.3.20. Mylan N.V 46. Primary Key Insights